<DOC>
	<DOCNO>NCT00396799</DOCNO>
	<brief_summary>The primary objective evaluate bioequivalence bazedoxifene/conjugated estrogens tablet produce use current manufacturing process bazedoxifene/conjugated estrogen tablet produce use new manufacturing process</brief_summary>
	<brief_title>Bioequivalence Study Of Bazedoxifene/Conjugated Estrogen Tablets In Postmenopausal Women</brief_title>
	<detailed_description />
	<mesh_term>Estrogens , Conjugated ( USP )</mesh_term>
	<mesh_term>Estrogens</mesh_term>
	<mesh_term>Bazedoxifene</mesh_term>
	<criteria>Inclusion Criteria Healthy , postmenopausal woman age 35 70 year weigh least 50 kg ( approx . 110 lb ) . At least 6 month spontaneous amenorrhea ( folliclestimulating hormone level 39 mIU/mL great ) . Nonsmoker smoker few 10 cigarette per day , ability abstain 5 day . Exclusion Criteria Women amenorrhea start 54 year age . A history active presence clinically important medical disease . Use oral estrogen , progestin , androgen , SERMcontaining drug product within 30 day receive study drug .</criteria>
	<gender>Female</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>